{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T07:30:35Z","timestamp":1764401435029},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2003,8,10]],"date-time":"2003-08-10T00:00:00Z","timestamp":1060473600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/1471-2334-3-17","type":"journal-article","created":{"date-parts":[[2003,8,27]],"date-time":"2003-08-27T06:44:55Z","timestamp":1061966695000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Safety and immunogenicity of three doses of an eleven-valent diphtheria toxoid and tetanus protein \u2013 conjugated pneumococcal vaccine in Filipino infants"],"prefix":"10.1186","volume":"3","author":[{"given":"Maria Z Rosario","family":"Capeding","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taneli","family":"Puumalainen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Connie P","family":"Gepanayao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helena","family":"K\u00e4yhty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marilla G","family":"Lucero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanna","family":"Nohynek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2003,8,10]]},"reference":[{"issue":"Suppl 1","key":"72_CR1","doi-asserted-by":"publisher","first-page":"S79","DOI":"10.1016\/S0264-410X(99)00112-7","volume":"17","author":"K Mulholland","year":"1999","unstructured":"Mulholland K: Strategies for the control of pneumococcal diseases. Vaccine. 1999, 17 (Suppl 1): S79-84. 10.1016\/S0264-410X(99)00112-7.","journal-title":"Vaccine"},{"key":"72_CR2","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1086\/338642","volume":"34","author":"E Vuori-Holopainen","year":"2002","unstructured":"Vuori-Holopainen E, Salo E, Saxen H, et al: Etiological diagnosis of childhood pneumonia by use of transthoracic needle aspiration and modern microbiological methods. Clin Infect Dis. 2002, 34: 583-590. 10.1086\/338642.","journal-title":"Clin Infect Dis"},{"key":"72_CR3","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/00006454-200003000-00003","volume":"19","author":"S Black","year":"2000","unstructured":"Black S, Shinefield H, Fireman B, Lewis E, Ray P, Hansen JR, Elvin L, Ensor KM, Hackell J, Siber G, Malinoski F, Madore D, Chang I, Kohberger R, Watson W, Austrian R, Edwards K: Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group [see comments]. Pediatr Infect Dis J. 2000, 19: 187-195. 10.1097\/00006454-200003000-00003.","journal-title":"Pediatr Infect Dis J"},{"key":"72_CR4","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1097\/00006454-200112000-00002","volume":"20","author":"S Black","year":"2001","unstructured":"Black S, Shinefield H, Hansen J, Elvin L, Laufer D, Malinoski F: Postlicensure evaluation of the effectiveness of seven valent pneumococcal conjugate vaccine. Pediatric Infectious Diseases Journal. 2001, 20: 1105-1107. 10.1097\/00006454-200112000-00002.","journal-title":"Pediatric Infectious Diseases Journal"},{"key":"72_CR5","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1097\/00006454-200209000-00005","volume":"21","author":"SB Black","year":"2002","unstructured":"Black SB, Shinefield H, Ling S, et al: Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia. Pediatric Infectious Diseases Journal. 2002, 21: 810-816. 10.1097\/00006454-200209000-00005.","journal-title":"Pediatric Infectious Diseases Journal"},{"key":"72_CR6","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJM200102083440602","volume":"344","author":"J Eskola","year":"2001","unstructured":"Eskola J, Kilpi T, Palmu A, Jokinen J, Haapakoski J, Herva E, Takala A, Kayhty H, Karma P, Kohberger R, Siber G, Makela PH: Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med. 2001, 344: 403-409. 10.1056\/NEJM200102083440602.","journal-title":"N Engl J Med"},{"key":"72_CR7","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1086\/313608","volume":"30","author":"WP Hausdorff","year":"2000","unstructured":"Hausdorff WP, Bryant J, Paradiso PR, Siber GR: Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I. Clin Infect Dis. 2000, 30: 100-121. 10.1086\/313608.","journal-title":"Clin Infect Dis"},{"key":"72_CR8","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1093\/infdis\/172.5.1273","volume":"172","author":"H Kayhty","year":"1995","unstructured":"Kayhty H, Ahman H, Ronnberg PR, Tillikainen R, Eskola J: Pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine is immunogenic in infants and children. J Infect Dis. 1995, 172: 1273-1278.","journal-title":"J Infect Dis"},{"key":"72_CR9","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1097\/00006454-200204000-00010","volume":"21","author":"T Puumalainen","year":"2002","unstructured":"Puumalainen T, Zeta-Capeding MR, Kayhty H, Lucero M, Auranen K, Leroy O, Nohynek H: Antibody response to an eleven-valent pneumococcal connjugate vaccine in Filipino infants. Pediatr Infect Dis J. 2002, 21: 309-314. 10.1097\/00006454-200204000-00010.","journal-title":"Pediatr Infect Dis J"},{"key":"72_CR10","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1086\/323648","volume":"184","author":"T Wuorimaa","year":"2001","unstructured":"Wuorimaa T, Dagan R, Vakevainen M, et al: Avidity and subclass of IgG after immunization of infants with an 11-valent pneumococcal conjugate vaccine with and without aluminium adjuvant. J Infect Dis. 2001, 184: 1211-1215. 10.1086\/323648.","journal-title":"J Infect Dis"},{"key":"72_CR11","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1097\/00006454-200103000-00011","volume":"20","author":"T Wuorimaa","year":"2001","unstructured":"Wuorimaa T, Dagan R, Eskola J, Janco J, Ahman H, Leroy O, Kayhty H: Tolerability and immunogenicity of an eleven-valent pneumococcal conjugate vaccine in healthy toddlers. Pediatr Infect Dis J. 2001, 20: 272-277. 10.1097\/00006454-200103000-00011.","journal-title":"Pediatr Infect Dis J"},{"key":"72_CR12","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1086\/313907","volume":"31","author":"KM Miernyk","year":"2000","unstructured":"Miernyk KM, Parkinson AJ, Rudolph KM, Petersen KM, Bulkow LR, Greenberg DP, Ward JI, Brenneman G, Reid R, Santosham M: Immunogenicity of a heptavalent pneumococcal conjugate vaccine in apache and navajo indian, alaska native, and non-native american children aged <2 years [In Process Citation]. Clin Infect Dis. 2000, 31: 34-41. 10.1086\/313907.","journal-title":"Clin Infect Dis"},{"key":"72_CR13","doi-asserted-by":"publisher","first-page":"I1171","DOI":"10.1086\/315009","volume":"180","author":"N Mbelle","year":"1999","unstructured":"Mbelle N, Huebner RE, Wasas AD, Kimura A, Chang I, Klugman KP: mmunogenicity and impact on nasopharyngeal carriage of a nonavalent pneumococcal conjugate vaccine. J Infect Dis. 1999, 180: I1171-1176. 10.1086\/315009.","journal-title":"J Infect Dis"},{"key":"72_CR14","first-page":"56","volume-title":"Scand J Immunol","author":"T Wuorimaa","year":"2002","unstructured":"Wuorimaa T, Kayhty H: Current state of pneumococcal vaccines. Scand J Immunol. 2002, 56-"},{"key":"72_CR15","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1097\/00006454-199906000-00015","volume":"18","author":"J Eskola","year":"1999","unstructured":"Eskola J, Anttila M: Pneumococcal conjugate vaccines. Pediatr Infect Dis J. 1999, 18: 543-551. 10.1097\/00006454-199906000-00015.","journal-title":"Pediatr Infect Dis J"},{"key":"72_CR16","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1016\/S0264-410X(00)00441-2","volume":"19","author":"T Wuorimaa","year":"2001","unstructured":"Wuorimaa T, Kayhty H, Leroy O, Eskola J: Tolerability and immunogenicity of an 11-valent pneumococcal conjugate vaccine in adults. Vaccine. 2001, 19: 1863-1869. 10.1016\/S0264-410X(00)00441-2.","journal-title":"Vaccine"},{"key":"72_CR17","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/0264-410X(95)00011-O","volume":"1995","author":"RK Gupta","year":"1995","unstructured":"Gupta RK, Siber G: Adjuvants for human vaccines-current status, problems and prospects. Vaccine. 1995, 1995: 1263-1276. 10.1016\/0264-410X(95)00011-O.","journal-title":"Vaccine"},{"key":"72_CR18","doi-asserted-by":"publisher","first-page":"S24","DOI":"10.1016\/S0264-410X(02)00168-8","volume":"20","author":"CJ Clements","year":"2002","unstructured":"Clements CJ, Griffiths E: The global impact of vaccines containing aluminium adjuvants. Vaccine. 2002, 20: S24-33. 10.1016\/S0264-410X(02)00168-8.","journal-title":"Vaccine"},{"key":"72_CR19","doi-asserted-by":"publisher","first-page":"S292","DOI":"10.1086\/322565","volume":"33","author":"H Kayhty","year":"2001","unstructured":"Kayhty H, Ahman H: Bridging phase 2 and phase 3 pneumococcal immunologic data for future combination vaccines. Clin Infect Dis. 2001, 33: S292-298. 10.1086\/322565.","journal-title":"Clin Infect Dis"},{"key":"72_CR20","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1097\/00006454-199712000-00007","volume":"16","author":"SK Obaro","year":"1997","unstructured":"Obaro SK, Huo Z, Banya WA, Henderson DC, Monteil MA, Leach A, Greenwood BM: A glycoprotein pneumococcal conjugate vaccine primes for antibody responses to a pneumococcal polysaccharide vaccine in Gambian children. Pediatr Infect Dis J. 1997, 16: 1135-1140. 10.1097\/00006454-199712000-00007.","journal-title":"Pediatr Infect Dis J"},{"key":"72_CR21","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1097\/00006454-199803000-00008","volume":"17","author":"H Ahman","year":"1998","unstructured":"Ahman H, Kayhty H, Lehtonen H, Leroy O, Froeschle J, Eskola J: Streptococcus pneumoniae capsular polysaccharide-diphtheria toxoid conjugate vaccine is immunogenic in early infancy and able to induce immunologic memory. Pediatr Infect Dis J. 1998, 17: 211-216. 10.1097\/00006454-199803000-00008.","journal-title":"Pediatr Infect Dis J"},{"key":"72_CR22","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S1473-3099(01)00063-9","volume":"1","author":"K Klugman","year":"2001","unstructured":"Klugman K: Efficacy of pneumococcal conjugate vaccines and their effect on carriage and antimicrobial resistance. The Lancet Infectious Diseases. 2001, 1: 85-91. 10.1016\/S1473-3099(01)00063-9.","journal-title":"The Lancet Infectious Diseases"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-3-17.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-3-17\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-3-17","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-3-17.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T16:02:53Z","timestamp":1726243373000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-3-17"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,8,10]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2003,12]]}},"alternative-id":["72"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-3-17","relation":{},"ISSN":["1471-2334"],"issn-type":[{"type":"electronic","value":"1471-2334"}],"subject":[],"published":{"date-parts":[[2003,8,10]]},"assertion":[{"value":"7 March 2003","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2003","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2003","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"17"}}